Softwr

Research · head to head

Sapio Sciences vs Seven Bridges

Sapio Sciences logo

Sapio Sciences

Research

Science-aware laboratory platform combining LIMS, ELN and scientific data management

From
On request
Rated
-
Full reviewWebsite
Seven Bridges logo

Seven Bridges

Research

Cloud bioinformatics platform and trusted research environment, sold by Velsera

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Sapio Sciences smaller vendor than the enterprise incumbents, which conservative laboratory procurement weights heavily for a system that must last a decade; Seven Bridges the parent merged into Velsera in 2023 alongside Pierian and UgenTec, so the platform now competes for roadmap attention with clinical interpretation and diagnostics products inside a private equity owned group.
  • They diverge on capability: Sapio Sciences covers Unified LIMS and ELN, Seven Bridges covers Trusted research environment.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Sapio Sciences and Seven Bridges actually diverge.

Attributes where Sapio Sciences and Seven Bridges differ
AttributeSapio SciencesSeven Bridges
PlatformsWeb, Cloud, On-premiseWeb, API, Cloud

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Sapio Sciences

  • Unified LIMS and ELN
  • No-code configuration
  • Scientific data management
  • Science-aware data model
  • Analysis tools
  • Regulated support

Only in Seven Bridges

  • Trusted research environment
  • Cloud-agnostic
  • CWL pipelines
  • Compliance certifications
  • Cost prediction
  • Public data commons
  • Collaboration
  • Tool library

What people use each for

The jobs each tool is most often brought in to do.

Sapio Sciences

  • Laboratories whose workflows change often enough that vendor change requests become the bottlenecknot Seven Bridges
  • Biotech organisations needing LIMS and ELN on one data modelnot Seven Bridges
  • Research groups wanting scientific staff to own configuration rather than ITnot Seven Bridges
  • Organisations replacing a rigid legacy LIMS they can no longer adaptnot Seven Bridges

Seven Bridges

  • A cancer genomics group analysing controlled-access dbGaP data that cannot be moved to local infrastructurenot Sapio Sciences
  • A federal or federally funded programme that needs FedRAMP Moderate authorisation for its analysis environmentnot Sapio Sciences
  • A multi-institution consortium sharing pipelines and results under defined access controls rather than by emailing filesnot Sapio Sciences
  • A diagnostics developer building reproducible CWL pipelines that must stand up to later regulatory reviewnot Sapio Sciences

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Sapio Sciences

  • Smaller vendor than the enterprise incumbents, which conservative laboratory procurement weights heavily for a system that must last a decade
  • Pricing is not published, so early comparison requires a sales process
  • No-code configuration still requires someone with the time and inclination to learn it, and laboratories that assign nobody end up where they started
  • Smaller partner ecosystem and fewer independent implementation resources
  • Less accumulated regulatory validation precedent than LabWare, which matters for inspected pharmaceutical QC

Seven Bridges

  • The parent merged into Velsera in 2023 alongside Pierian and UgenTec, so the platform now competes for roadmap attention with clinical interpretation and diagnostics products inside a private equity owned group.
  • Pricing is not published and splits into a platform subscription plus consumption-based cloud compute, so a heavy analysis quarter produces a bill that headcount-based budgeting does not anticipate.
  • The analysis capability itself has credible open source equivalents in Nextflow and Cromwell on raw cloud, so you are principally paying for compliance and governance rather than for the science.
  • Pipelines are built around Common Workflow Language, which is a real learning curve and a portability commitment for teams whose existing work is in other workflow languages.
  • Cloud storage of large genomic datasets accrues continuously whether or not you are analysing, and egress charges apply when moving results out, both of which are outside the subscription line.

Pricing, plan by plan

Sapio Sciences

On request
  • Sapio Platform$undefined/year
    • LIMS
    • ELN
    • Scientific data management

Seven Bridges

On request
  • Seven Bridges Platform$undefined/year
    • Platform subscription quoted through Velsera sales
    • Cloud compute and storage charged on consumption on top of the subscription
    • Cost predictor tools provided to estimate analysis spend in advance

Which should you pick?

Choose Sapio Sciences if

  • You need unified lims and eln.
  • You work on Web, Cloud, On-premise.
  • You also want no-code configuration.
Sapio Sciences review

Choose Seven Bridges if

  • You need trusted research environment.
  • You work on Web, API, Cloud.
  • You also want cloud-agnostic.
Seven Bridges review

Questions people ask

Is Sapio Sciences or Seven Bridges better?
Neither clearly leads. Sapio Sciences starts at On request and Seven Bridges at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Sapio Sciences or Seven Bridges?
Sapio Sciences starts at On request and Seven Bridges at On request.
Does Sapio Sciences or Seven Bridges run on more platforms?
Sapio Sciences runs on Web, Cloud, On-premise. Seven Bridges runs on Web, API, Cloud.
What is Sapio Sciences best used for?
Sapio Sciences is most often used for laboratories whose workflows change often enough that vendor change requests become the bottleneck, biotech organisations needing lims and eln on one data model, research groups wanting scientific staff to own configuration rather than it, organisations replacing a rigid legacy lims they can no longer adapt. Of those, laboratories whose workflows change often enough that vendor change requests become the bottleneck and biotech organisations needing lims and eln on one data model are not what Seven Bridges is typically brought in for.
What can Sapio Sciences do that Seven Bridges cannot?
Sapio Sciences covers Unified LIMS and ELN, No-code configuration, Scientific data management, Science-aware data model. Seven Bridges covers Trusted research environment, Cloud-agnostic, CWL pipelines, Compliance certifications.

Answered from the vendors’ own pages

Sapio Sciences: What is the no-code claim actually about?

Changing workflows, data models and screens without a vendor services engagement. The problem it targets is real: most LIMS are configured once at implementation and every later change becomes a costly change request.

Seven Bridges: Is Seven Bridges still sold?

Yes. It is sold by Velsera, formed in 2023 when Summa Equity merged Seven Bridges with Pierian and UgenTec. The Seven Bridges name was retained for the platform.

Sapio Sciences: Does no-code mean no effort?

No. Someone in the laboratory has to learn the configuration model and own it. Laboratories that assign nobody end up with the same rigidity they were escaping.

Seven Bridges: What compliance does it hold?

FedRAMP Moderate, SOC 2, HIPAA, GDPR, dbGaP and ISO 27001, 27017, 27018 and 27701, which is the usual reason institutions choose it over building on raw cloud.

Sapio Sciences: What does it cost?

Not published. Annual enterprise licensing quoted on users and modules.

Seven Bridges: How is it priced?

Not published. Expect a platform subscription plus consumption charges for cloud compute and storage.

Sapio Sciences: Is it suitable for regulated QC?

It supports regulated environments, but LabWare and STARLIMS have far more accumulated validation precedent. For inspected pharmaceutical QC that history carries real weight.

Seven Bridges: Do I have to use a specific cloud?

No. The platform is cloud-agnostic and designed to bring analysis to where the data already resides.

Sapio Sciences: How does it compare to Benchling?

Both are modern and science-aware. Benchling is stronger in research molecular biology; Sapio positions more toward configurable LIMS and ELN across research and regulated work.

Share

Related pages

More on Sapio Sciences

More on Seven Bridges

Keep looking

Other head to heads